Santarusincis A Specialty Biopharmaceutical Company Founded In 1996Focused On Acquiringdevelopingand Commercializing Proprietary Products For Patients Treated By Physician Specialiststhe Company Has A Presence In Both San Diegocaliforniaand Raleighnorth Carolina Santarus Develops And Markets Pharmaceutical Products With New Formulations And Enhanced Delivery Systemstheir Product Lineup Includes Uceris For Ulcerative Colitiszegerid For Gastrointestinal Disordersglumetza And Cycloset For Type 2 Diabetes Managementand Fenoglide For High Cholesterolthe Company Is Also Involved In Developing Investigational Drugs Like Ruconest For Hereditary Angioedema And Rifamycin Sv Mmxwhich Is In Phase Iii Clinical Testing For Travelersdiarrheasantarus Operates As A Subsidiary Of Salix Pharmaceuticalsincsince December 312013
